{"id":"W2597077431","doi":"10.1200/jco.2013.31.15_suppl.2093","title":"Phase I/II study of dianhydrogalactitol in patients with recurrent malignant glioma or progressive secondary brain tumor.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Temozolomide; Medicine; Radiation therapy; Glioma; Oncology; Bevacizumab; Brain tumor; Internal medicine; Chemotherapy; Pathology; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006798445,0.00181509,0.001952534,0.0004337527,0.0003323561,0.0006615272,0.0009193027,0.001075542,0.00277784],"category_scores_gemma":[0.000365972,0.000522813,0.001143503,0.0004286235,0.0009492424,0.0004759135,0.000300072,0.002807693,0.001015674],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009817189,"about_ca_system_score_gemma":0.001698954,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001804025,"about_ca_topic_score_gemma":0.003961954,"domain_scores_codex":[0.9997678,0.00007639125,0.0000110239,0.00005111848,0.0000231063,0.00007061391],"domain_scores_gemma":[0.9996556,0.00003184346,0.00005347117,0.00003415058,0.00002684393,0.0001980286],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5541438,0.1403521,0.01137266,0.001208067,0.002162699,0.0008240265,0.0006413823,0.003924863,0.1499624,0.0005207807,0.008626258,0.126261],"study_design_scores_gemma":[0.2874105,0.6816644,0.01453785,0.00003100311,0.0005678556,0.0007257756,0.0001101183,0.001692224,0.008589292,0.0002675561,0.004361287,0.00004210953],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947227,0.001130361,0.0004175326,0.0002504751,0.00008276771,0.001449048,0.0007307336,0.00009906857,0.001117381],"genre_scores_gemma":[0.9915685,0.001146591,0.001292213,0.0006426906,0.00007441725,0.001488098,0.001829115,0.0000383606,0.00192002],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00277784,"threshold_uncertainty_score":0.009292841,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05672199724298657,"score_gpt":0.4328534423043013,"score_spread":0.3761314450613147,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}